Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
Curreli, Francesca, Ahmed, Shahad, Victor, Sofia M B, Drelich, Aleksandra, Panda, Siva S, Altieri, Andrea, Kurkin, Alexander V, Tseng, Chien-Te K, Hillyer, Christopher D, Debnath, Asim K
Published in Viruses (31.12.2021)
Published in Viruses (31.12.2021)
Get full text
Journal Article
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
Curreli, Francesca, Victor, Sofia M B, Ahmed, Shahad, Drelich, Aleksandra, Tong, Xiaohe, Tseng, Chien-Te K, Hillyer, Christopher D, Debnath, Asim K
Published in mBio (11.12.2020)
Published in mBio (11.12.2020)
Get full text
Journal Article
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection italic toggle="yes">In Vitro /italic
Francesca Curreli, Sofia M. B. Victor, Shahad Ahmed, Aleksandra Drelich, Xiaohe Tong, Chien-Te K. Tseng, Christopher D. Hillyer, Asim K. Debnath
Published in mBio (01.12.2020)
Published in mBio (01.12.2020)
Get full text
Journal Article
Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)
Curreli, Francesca, Shahad Ahmed, Victor, Sofia M B, Drelich, Aleksandra, Panda, Siva S, Altieri, Andrea, Kurkin, Alexander, Tseng, Chien-Te, Hillyer, Christopher, Debnath, Asim
Published in bioRxiv (17.09.2021)
Published in bioRxiv (17.09.2021)
Get full text
Paper
Stapled peptides based on Human Angiotensin-Converting Enzyme 2 (ACE2) potently inhibit SARS-CoV-2 infection in vitro
Curreli, Francesca, Victor, Sofia M B, Shahad Ahmed, Drelich, Aleksandra, Tong, Xiaohe, Tseng, Chien-Te K, Hillyer, Christopher D, Debnath, Asim K
Published in bioRxiv (11.11.2020)
Published in bioRxiv (11.11.2020)
Get full text
Paper